In a patient with low total iron‑binding capacity, low red blood cell count, and normal‑high mean corpuscular hemoglobin, what is the most likely diagnosis and what further evaluation should be performed?

Anemia of Chronic Disease

The most likely diagnosis is anemia of chronic disease (ACD), and you should immediately measure serum ferritin, C-reactive protein (CRP), and assess for underlying chronic inflammatory conditions such as chronic kidney disease, heart failure, inflammatory bowel disease, or malignancy.

Clinical Reasoning

The combination of low total iron-binding capacity (TIBC) with low red blood cell count and normal-to-high mean corpuscular hemoglobin (MCH) is pathognomonic for anemia of chronic disease, not iron deficiency anemia 1. This is a critical distinction:

Key Differentiating Features

Low TIBC strongly predicts ACD:

• Only 3% of patients with TIBC ≤250 µg/dL have iron deficiency 1
• In contrast, 54% of patients with TIBC ≥350 µg/dL have iron deficiency 1
• ACD is characterized by low serum iron AND low TIBC, whereas iron deficiency shows low serum iron but HIGH TIBC 2, 3

The normal-to-high MCH argues against iron deficiency:

• Iron deficiency typically presents with low MCH (hypochromic cells)
• MCH ≥86 fL has 98% negative predictive value for iron deficiency 1
• Your patient's normal-high MCH makes iron deficiency highly unlikely

Immediate Diagnostic Workup

First-Line Tests (Order Now):

1. Serum ferritin - The single most important test 4

   • In ACD: Often elevated (>100 ng/mL) due to acute-phase reactant properties
   • In iron deficiency: <25 ng/mL (males) or <11 ng/mL (females) 4
   • Caveat: Ferritin can be falsely elevated in inflammation, making interpretation challenging 4

2. Transferrin saturation (serum iron/TIBC × 100)

   • More reliable than ferritin in inflammatory states 4
   • ACD: Usually <20% with low TIBC
   • Iron deficiency: <20% with high TIBC

3. C-reactive protein (CRP)

   • Confirms inflammatory state
   • Helps interpret elevated ferritin levels 4

4. Complete metabolic panel with creatinine

   • Screen for chronic kidney disease (24-85% have iron deficiency/ACD) 5

Second-Line Tests (Based on Initial Results):

1. Reticulocyte count

   • Low count in ACD suggests inadequate erythropoietin production or inflammation 4
   • Helps assess bone marrow response

2. Red cell distribution width (RDW)

   • 94% sensitivity for iron deficiency 6
   • Normal RDW essentially excludes iron deficiency when ferritin is equivocal 6

Search for Underlying Chronic Disease

ACD requires identification of the causative condition 3. Systematically evaluate for:

High-Yield Conditions to Screen:

• Chronic kidney disease: Check creatinine, eGFR (prevalence 24-85%) 5
• Heart failure: Clinical assessment, BNP if indicated (prevalence 37-61%) 5
• Inflammatory bowel disease: Consider fecal calprotectin, colonoscopy (prevalence 13-90%) 5
• Malignancy: Age-appropriate cancer screening, especially GI tract (prevalence 18-82%) 5
• Chronic infections: HIV, hepatitis C, tuberculosis
• Autoimmune diseases: Rheumatoid arthritis, lupus

Critical Pitfall to Avoid

Do not empirically treat with oral iron without confirming the diagnosis. In ACD, iron supplementation is ineffective because the problem is functional iron deficiency (iron sequestration), not absolute iron deficiency 3. The best treatment for ACD is addressing the underlying chronic disorder 3. If ACD persists despite treating the underlying condition, consider erythropoietin-stimulating agents and intravenous iron (not oral) 3.

When to Consult Hematology

Refer if 4:

• Abnormalities in two or more cell lines (WBC, hemoglobin, platelets)
• Diagnosis remains unclear after initial workup
• Suspected hemoglobinopathy or bone marrow disorder
• Refractory anemia despite treating underlying condition